 |
Medication Safety Officers Society 3703 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
Hello,
We are seeing an increase in the use of BUPivacaine (Liposomal) by our surgeons. How have you provided clinical decision support to not administer other local anesthetics or other formulations of bupivacaine within 96 hours following bupivacaine (liposomal) administration? Do your pharmacists receive any kind of alert?
Thank you in advance.
Damon